» Articles » PMID: 20940627

Location of Prorenin Receptors in Primate Substantia Nigra: Effects on Dopaminergic Cell Death

Overview
Specialties Neurology
Pathology
Date 2010 Oct 14
PMID 20940627
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Angiotensin II acts via angiotensin type 1 receptors and is a major inducer of inflammation and oxidative stress. Local renin-angiotensin systems play a major role in the development of age-related disorders in several tissues. These processes are delayed, but not totally abolished, by blockade of angiotensin signaling. A specific receptor for renin and its precursor prorenin has recently been identified. We previously showed that neurotoxin-induced dopaminergic (DA) cell loss is decreased by inhibition of angiotensin receptors, but the location and functional effects of prorenin receptor (PRR) in the brain, including the DA system, are unknown. In the substantia nigra of Macaca fascicularis and in rat primary mesencephalic cultures, double immunofluorescence analysis revealed PRR immunoreactivity in neurons (including DA neurons) and microglia, but not in astrocytes. Administration of the PRR blocker, handle region peptide, led to a significant decrease in 6-hydroxydopamine-induced DA cell death in the cultures,whereas administration of renin with simultaneous blockade of angiotensin receptors led to an increase in 6-hydroxydopamine-induced cell death. These results suggest that active agent angiotensin II-independent PRR intracellular signaling may contribute to exacerbation of DA cell death in vivo. Therefore, potential neuroprotective strategies for DA neurons in Parkinson disease should address both angiotensin and PRR signaling.

Citing Articles

ATP6AP2, a regulator of LRP6/β-catenin protein trafficking, promotes Wnt/β-catenin signaling and bone formation in a cell type dependent manner.

Xiong L, Guo H, Pan J, Ren X, Lee D, Chen L Bone Res. 2024; 12(1):33.

PMID: 38811544 PMC: 11137048. DOI: 10.1038/s41413-024-00335-7.


The role of the brain renin-angiotensin system in Parkinson´s disease.

Labandeira-Garcia J, Labandeira C, Guerra M, Rodriguez-Perez A Transl Neurodegener. 2024; 13(1):22.

PMID: 38622720 PMC: 11017622. DOI: 10.1186/s40035-024-00410-3.


Extracellular Vesicles and Their Renin-Angiotensin Cargo as a Link between Metabolic Syndrome and Parkinson's Disease.

Pedrosa M, Labandeira C, Lago-Baameiro N, Valenzuela R, Pardo M, Labandeira-Garcia J Antioxidants (Basel). 2023; 12(12).

PMID: 38136165 PMC: 10741149. DOI: 10.3390/antiox12122045.


NADPH-Oxidase, Rho-Kinase and Autophagy Mediate the (Pro)renin-Induced Pro-Inflammatory Microglial Response and Enhancement of Dopaminergic Neuron Death.

Lopez-Lopez A, Villar-Cheda B, Quijano A, Garrido-Gil P, Garcia-Garrote M, Diaz-Ruiz C Antioxidants (Basel). 2021; 10(9).

PMID: 34572972 PMC: 8472832. DOI: 10.3390/antiox10091340.


The Renin-Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene.

Kobiec T, Otero-Losada M, Chevalier G, Udovin L, Bordet S, Menendez-Maissonave C Front Synaptic Neurosci. 2021; 13:638519.

PMID: 33967734 PMC: 8100578. DOI: 10.3389/fnsyn.2021.638519.